OTC Medicines

In a new letter, ACI and CHPA call on FDA to withdraw its temporary guidance for the manufacturing of alcohol-based hand sanitizer products.

CHPA congratulates Patrizia Cavazzoni on her recent appointment as director of FDA’s Center for Drug Evaluation and Research (CDER).

CHPA congratulates Xavier Becerra upon his confirmation by the U.S. Senate as Secretary of the Department of Health & Human Services (HHS).

In a major victory for consumer health, today Mississippi has repealed an 11-year-old law that banned over-the-counter (OTC) sales of certain medicines for colds and allergies containing the decongestant pseudoephedrine (PSE).

CHPA welcomes Church & Dwight, Co., Inc., Bridges Consumer Healthcare, and Rhinomed Inc. as its newest manufacturer members of the association.

Recent media reports have cited infectious disease experts who recommend against premedicating with over-the-counter (OTC) pain relievers, like those containing acetaminophen and ibuprofen, when getting a COVID-19 vaccine.